Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Compliance with antimicrobial therapy for buruli ulcer.

Literature DB >> 25225342

Compliance with antimicrobial therapy for buruli ulcer.

S Klis¹, R Kingma², W Tuah³, Y Stienstra², T S van der Werf⁴.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2014 PMID： 25225342 PMCID： PMC4187936 DOI： 10.1128/AAC.03763-14

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

4 in total

1. Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.

Authors: Annick Chauty; Marie-Françoise Ardant; Laurent Marsollier; Gerd Pluschke; Jordi Landier; Ambroise Adeye; Aimé Goundoté; Jane Cottin; Titilola Ladikpo; Therese Ruf; Baohong Ji
Journal: Clin Infect Dis Date: 2011-01-01 Impact factor: 9.079

2. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.

Authors: Willemien A Nienhuis; Ymkje Stienstra; William A Thompson; Peter C Awuah; K Mohammed Abass; Wilson Tuah; Nana Yaa Awua-Boateng; Edwin O Ampadu; Vera Siegmund; Jan P Schouten; Ohene Adjei; Gisela Bretzel; Tjip S van der Werf
Journal: Lancet Date: 2010-02-03 Impact factor: 79.321

3. Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.

Authors: Richard O Phillips; Fred S Sarfo; Mohammed K Abass; Justice Abotsi; Tuah Wilson; Mark Forson; Yaw A Amoako; William Thompson; Kingsley Asiedu; Mark Wansbrough-Jones
Journal: Antimicrob Agents Chemother Date: 2013-12-09 Impact factor: 5.191

4. Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.

Authors: Sandor Klis; Ymkje Stienstra; Richard O Phillips; Kabiru Mohammed Abass; Wilson Tuah; Tjip S van der Werf
Journal: PLoS Negl Trop Dis Date: 2014-03-13

4 in total

3 in total

Compliance with antimicrobial therapy for buruli ulcer.

1. Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.

2. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.

3. Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.

4. Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.

1. Reply to "compliance with antimicrobial therapy for buruli ulcer".

2. Barriers to Buruli ulcer treatment completion in the Ashanti and Central Regions, Ghana.

Review 3. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).